Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
AboutMethodSourcesNewsletter
Insider tradingForm 4

Candel Therapeutics, Inc. (CADL) Insider Trading

3 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 3 sales worth $3.24M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Paul Peter TakCEO0$02$3.16MSep 11, 2026
Seshu TyagarajanCTO0$01$84KAug 19, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

CADL insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 11Sep 10Paul Peter TakCEOCEO▼ SELL10b5-1220,86611.50$2.54M−56%Form 4 ↗
Sep 11Sep 11Paul Peter TakCEOCEO▼ SELL10b5-159,37910.46$621K−34%Form 4 ↗
Aug 19Aug 17Seshu TyagarajanCTOCTO▼ SELL10b5-17,00012.00$84K−8.3%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings